183
Participants
Start Date
November 29, 2025
Primary Completion Date
September 11, 2028
Study Completion Date
September 11, 2028
IGI, 10%
IGI, 10% IV infusion.
New York Oncology Hematology, Albany
East Carolina University, Greenville
Infirmary Health - Diagnostic & Medical Clinic (DMC), Mobile
Cleveland Clinic, Cleveland
Henry Ford Health System, Detroit
Washington University School of Medicine, St Louis
University of Kansas, Westwood
Chao Family Comprehensive Cancer Center UCI, Orange
"University of Maryland , Greenebaum Cancer Center"
Northwest Anglia Foundation Trust, Peterborough
Royal Devon And Exeter Hospital, Exeter
Colchester General Hospital, Colcester
Gloucestershire Royal Hospital, Gloucester
Cardiff & Vale University Health Board, Cardiff
Harrogate and District NHS Foundation Trust, Harrogate
Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes
County Hospital (Stafford Hospital), Stafford
Lead Sponsor
Takeda Development Center Americas, Inc.
INDUSTRY
Baxalta Innovations GmbH, now part of Takeda
UNKNOWN
Takeda
INDUSTRY